Guy Jerusalem

Belgium

Research Interests

Explore related searches

Professors in Belgium

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (13)

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (12)

Mothaffar Rimawi

Professor, Executive Medical Director

Baylor College of Medicine

UNITED STATES

View details

Audrey Vanhaudenhuyse

BELGIUM

View details

Lore Decoster

Vrije Universiteit Brussel

BELGIUM

View details

Matthew Goetz

Professor of Oncology and Pharmacology

Mayo Clinic

UNITED STATES

View details

Peter A. van Dam

BELGIUM

View details

Giorgio Mustacchi

Università degli Studi di Torino

ITALY

View details

Stephen Johnston

Professor of Breast Cancer Medicine

Royal Marsden NHS Foundation Trust

UNITED KINGDOM

View details

Benoit You

FRANCE

View details

Sung-Bae Kim

University of Ulsan College of Medicine

SOUTH KOREA

View details

PIERFRANCO CONTE

Professore di 1^ fascia

University of Padova

ITALY

View details

Ahmad Awada

Université libre de Bruxelles (ULB)

BELGIUM

View details

DANIELE GENERALI

University of Trieste

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Guy Jerusalem

Research Interests

Explore related searches

Contact this professor

Articles (13)

Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial

Landscape of Baseline and Acquired Genomic Alterations in Circulating Tumor DNA with Abemaciclib Alone or with Endocrine Therapy in Advanced Breast Cancer

Neoadjuvant nivolumab + palbociclib + anastrozole for oestrogen receptor-positive/human epidermal growth factor receptor 2-negative primary breast cancer: Results from CheckMate 7A8

End-of-Life Care in the Last Three Months before Death in Older Patients with Cancer in Belgium: A Large Retrospective Cohort Study Using Data Linkage

Tucatinib and Trastuzumab for Previously Treated Human Epidermal Growth Factor Receptor 2–Positive Metastatic Biliary Tract Cancer (SGNTUC-019): A Phase II Basket Study

Trastuzumab Deruxtecan in HER2-Positive Metastatic Breast Cancer Patients with Brain Metastases: A DESTINY-Breast01 Subgroup Analysis

Randomized, Controlled Trial of an Intervention Combining Self-Care and Self-Hypnosis on Fatigue, Sleep, and Emotional Distress in Posttreatment Cancer Patients: 1-Year Follow-Up

Anthracyclines Strike Back: Rediscovering Non-Pegylated Liposomal Doxorubicin in Current Therapeutic Scenarios of Breast Cancer

Immunity and Breast Cancer: Focus on Eosinophils

Optimal treatment in locally advanced cervical cancer

Exploratory Controlled Study of the Impact of a Hypnosis-Based Intervention on the Couple’s Communication and Coping in the Context of Cancer

CDK4/6 inhibitors in breast cancer: differences in toxicity profiles and impact on agent choice. A systematic review and meta-analysis

Endocrine-Based Treatments in Clinically-Relevant Subgroups of Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Systematic Review and Meta-Analysis

Collaborators (12)

Mothaffar Rimawi

Audrey Vanhaudenhuyse

Lore Decoster

Matthew Goetz

Peter A. van Dam

Giorgio Mustacchi

Stephen Johnston

Benoit You

Sung-Bae Kim

PIERFRANCO CONTE

Ahmad Awada

DANIELE GENERALI

Make your next move.